Osaic Holdings’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
15,489
+874
+6% +$181K ﹤0.01% 1952
2026
Q1
$3.28M Buy
14,615
+3,118
+27% +$777K ﹤0.01% 1668
2025
Q4
$2.77M Sell
11,497
-1,294
-10% -$331K ﹤0.01% 1814
2025
Q3
$3.5M Buy
12,791
+836
+7% +$228K ﹤0.01% 1743
2025
Q2
$3.04M Sell
11,955
-24
-0.2% -$5.72K 0.01% 1583
2025
Q1
$2.68M Sell
11,979
-2,546
-18% -$594K 0.01% 1438
2024
Q4
$2.64M Sell
14,525
-1,701
-10% -$410K 0.01% 1451
2024
Q3
$3.96M Buy
16,226
+926
+6% +$207K 0.01% 1200
2024
Q2
$2.93M Sell
15,300
-3,843
-20% -$780K 0.01% 1371
2024
Q1
$3.79M Sell
19,143
-1,313
-6% -$241K 0.01% 1229
2023
Q4
$3.52M Buy
20,456
+5,540
+37% +$851K 0.01% 1444
2023
Q3
$2.21M Sell
14,916
-3,622
-20% -$655K ﹤0.01% 1906
2023
Q2
$4.05M Sell
18,538
-1,100
-6% -$245K 0.01% 1333
2023
Q1
$4.3M Sell
19,638
-3,704
-16% -$804K 0.01% 1262
2022
Q4
$4.86M Buy
23,342
+1,242
+6% +$273K 0.01% 1120
2022
Q3
$4.83M Sell
22,100
-2,064
-9% -$470K 0.01% 1040
2022
Q2
$5.07M Buy
24,164
+1,532
+7% +$326K 0.01% 1031
2022
Q1
$5.86M Sell
22,632
-136
-0.6% -$32.9K 0.01% 1076
2021
Q4
$5.93M Buy
22,768
+550
+2% +$143K 0.01% 1007
2021
Q3
$5.86M Sell
22,218
-882
-4% -$241K 0.01% 961
2021
Q2
$5.7M Sell
23,100
-968
-4% -$204K 0.01% 972
2021
Q1
$4.67M Sell
24,068
-5,336
-18% -$1.07M 0.01% 998
2020
Q4
$6.25M Sell
29,404
-1,545
-5% -$308K 0.02% 733
2020
Q3
$5.31M Sell
30,949
-882
-3% -$163K 0.02% 737
2020
Q2
$6.11M Sell
31,831
-5,634
-15% -$922K 0.02% 607
2020
Q1
$5.52M Buy
+37,465
New +$5.97M 0.02% 567

Other funds holding RMD

Osaic Holdings's RMD Position: Q2 2026 in Review

Osaic Holdings increased its ResMed (RMD) stake by 6% in Q2 2026, buying an estimated $181K and bringing the position to 15,489 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Osaic Holdings first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $6.25M in Q4 2020. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Osaic Holdings held 15,489 shares of ResMed worth $3.02M as of Q2 2026.
  • Osaic Holdings bought 874 ResMed shares in Q2 2026, an estimated $181K.
  • ResMed made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #1952 holding.
  • Osaic Holdings first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's ResMed position peaked at $6.25M in Q4 2020.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.